EUDA Health Holdings Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of May 2026 for EUDA Health Holdings Limited, a foreign private issuer headquartered in Singapore. The report primarily addresses regulatory compliance matters with The Nasdaq Stock Market regarding listing standards.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on listing status and does not contain financial performance data.
Material Changes
The material change reported is the restoration of compliance with Nasdaq listing requirements:
- April 23, 2026: The Company received notice of non-compliance with Nasdaq Listing Rule 5550(b)(2) due to failing to maintain a Minimum Market Value of Listed Securities (MVLS) of $35 million over 32 consecutive business days.
- May 28, 2026: The Company received notice of regained compliance after maintaining an MVLS of $35 million or greater for ten consecutive business days (May 13 to May 27, 2026).
Outlook, Risks, and Management Commentary
Management commentary is limited to the notification of the MVLS status change. The primary risk addressed was the potential delisting due to insufficient market value, which has been temporarily resolved. No forward-looking guidance or other contingencies are disclosed in this text.
Key Facts for Investor Verification
- Verify the current Market Value of Listed Securities to ensure continued compliance with the $35 million threshold.
- Monitor future Nasdaq communications for any recurrence of MVLS non-compliance.
- Review the attached press release (Exhibit 99.1) for additional context on the market value fluctuation.